Using the technology and making it work for purpose are two different things. And the U.S. leads all countries in terms of full implementation, at 24% (vs. 19% for China).

Oncologists using or considering AI tools tend to agree among themselves on three points of ethics—and to recognize the same number of ways AI could help advance the state of patient care. 

Is U.S. healthcare capable of achieving its own quadruple aim? Or is that ideal destined to remain a perpetual pursuit, always chased but never really caught?

Those who have been thinking healthcare could use a detailed framework on the responsible use of healthcare AI just got their wish.

A full 85% of 2,800 surveyed across 14 countries say they’re investing in the technology now or planning to do so within three years.

The American Medical Association adopted a policy calling for medical staff to be involved in decisions about adopting AI that may impact patient care.

AI won’t fulfill its promise to transform American medicine if it isn’t appropriately integrated, step by step, across U.S. healthcare.

AI transparency in medical devices is achievable and imperative, according to new guidance jointly promoted by the FDA, Health Canada and the U.K.’s Medicines and Healthcare products Regulatory Agency.